论文部分内容阅读
SM 3997SM 3997是一种新的非苯并二氮杂 类选择性抗焦虑药,由住友公司和辉瑞公司研制。在大鼠脑膜结合研究中发现,其对5-HT1A结合位点有很强的亲和力(Ki=28nm),而对多巴胺D-2和5-HT2结合位点的亲和力均较弱(Ki分别为650和...
SM 3997SM 3997 is a new non-benzodiazepine selective anti-anxiety drug developed by Sumitomo and Pfizer. It was found that there was a strong affinity for the 5-HT1A binding site (Ki = 28 nm) and a weak affinity for the dopamine D-2 and 5-HT2 binding sites in the rat brain meningo-junctional study 650 and ...